Cancer Vaccines Co-Targeting HER2/Neu and IGF1R

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R

(1) Background: Human epidermal growth factor receptor 2 (HER2)/neu-driven carcinogenesis is delayed by preventive vaccines able to elicit autochthonous antibodies against HER2/neu. Since cooperation between different receptor tyrosine kinases (RTKs) can occur in human as well as in experimental tum...

Full description

Bibliographic Details
Main Authors: Carla De Giovanni, Lorena Landuzzi, Arianna Palladini, Marianna Lucia Ianzano, Giordano Nicoletti, Francesca Ruzzi, Augusto Amici, Stefania Croci, Patrizia Nanni, Pier-Luigi Lollini
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Cancers
Subjects:
cancer vaccines
HER2/neu
IGF1R
muscle neoplasms
DNA vaccines
Online Access:https://www.mdpi.com/2072-6694/11/4/517

Internet

https://www.mdpi.com/2072-6694/11/4/517

Similar Items